We are live on
!
Find out more
BCM
BluePath Capital Management Portfolio holdings
AUM
$182M
1-Year Est. Return
38.9%
This Fund
S&P 500
This Quarter
Est. Return
-1.04%
1 Year Est. Return
+38.9%
3 Year Est. Return
+101.38%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$109M
AUM Growth
–
Cap. Flow
+$112M
Cap. Flow
% of AUM
102.53%
Top 10 Holdings %
Top 10 Hldgs %
49.02%
Holding
335
New
335
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nicholas Fixed Income Alternative ETF
FIAX
|
+$25.6M |
| 2 |
Zega Buy & Hedge ETF
ZHDG
|
+$11.7M |
| 3 |
Aflac
AFL
|
+$4.95M |
| 4 |
Microsoft
MSFT
|
+$2.21M |
| 5 |
Apple
AAPL
|
+$2.09M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 12.04% |
| 2 | Technology | 11.58% |
| 3 | Healthcare | 6.28% |
| 4 | Energy | 5.44% |
| 5 | Consumer Discretionary | 5.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
PROG Holdings
PRG
$1.71B
| $30.9K | 0.03% |
+929
| New | +$32.4K |
|
277
Xencor
XNCR
$1.45B
| $30.9K | 0.03% |
+1,531
| New | +$34.8K |
|
|
BCYC
278
Bicycle Therapeutics
BCYC
$269M
| $30.8K | 0.03% |
+1,534
| New | +$35.1K |
|
279
Camtek
CAMT
$5.92B
| $30.8K | 0.03% |
+494
| New | +$24.4K |
|
280
Beazer Homes USA
BZH
$888M
| $30.7K | 0.03% |
+1,234
| New | +$35.6K |
|
281
Eagle Materials
EXP
$6.49B
| $30.6K | 0.03% |
+184
| New | +$33.4K |
|
282
Castle Biosciences
CSTL
$742M
| $30.6K | 0.03% |
+1,811
| New | +$31.7K |
|
283
Toast
TOST
$18.9B
| $30.5K | 0.03% |
+1,626
| New | +$35.3K |
|
284
MongoDB
MDB
$25.8B
| $30.4K | 0.03% |
+88
| New | +$33.4K |
|
|
BLD
285
DELISTED
TopBuild
BLD
| $30.2K | 0.03% |
+120
| New | +$33.1K |
|
286
Sprinklr
CXM
$1.51B
| $30K | 0.03% |
+2,166
| New | +$31K |
|
287
Take-Two Interactive
TTWO
$46.1B
| $29.9K | 0.03% |
+213
| New | +$30.7K |
|
288
Delek US
DK
$3.98B
| $29.7K | 0.03% |
+1,046
| New | +$28.2K |
|
289
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$23B
| $29.6K | 0.03% |
+595
| New | +$29.8K |
|
290
NeoGenomics
NEO
$1.99B
| $29.6K | 0.03% |
+2,407
| New | +$35.8K |
|
291
Rockwell Automation
ROK
$51.1B
| $29.4K | 0.03% |
+103
| New | +$31.9K |
|
292
Clear Secure
YOU
$5.88B
| $29.4K | 0.03% |
+1,544
| New | +$34.2K |
|
|
PXD
293
DELISTED
Pioneer Natural Resource Co.
PXD
| $29.3K | 0.03% |
+128
| New | +$29.1K |
|
294
Alphatec Holdings
ATEC
$1.48B
| $29.1K | 0.03% |
+2,243
| New | +$35.1K |
|
295
Lennar Class A
LEN
$20.4B
| $29K | 0.03% |
+267
| New | +$31.3K |
|
296
Coty
COTY
$2.4B
| $28.9K | 0.03% |
+2,630
| New | +$31K |
|
297
American Express
AXP
$224B
| $28.5K | 0.03% |
+191
| New | +$31.2K |
|
298
Diamondback Energy
FANG
$56B
| $28.5K | 0.03% |
+184
| New | +$27.2K |
|
299
Arvinas
ARVN
$530M
| $28.4K | 0.03% |
+1,447
| New | +$35.5K |
|
300
Arcus Biosciences
RCUS
$3.33B
| $28.1K | 0.03% |
+1,568
| New | +$31.5K |
|
Similar funds
MAM
WA
ACG
CF
QC
RS
SPI
NED
BluePath Capital Management's Q3 2023 Portfolio in Review
Q3 2023 is the first quarter with a 13F filing on record for BluePath Capital Management, which disclosed 335 positions worth $109M. Its ten largest holdings account for 49% of the portfolio.
Its largest position is Nicholas Fixed Income Alternative ETF: 1,285,161 shares worth $25.1M.
By sector, the portfolio is most concentrated in Financials at 12% of assets, followed by Technology and Healthcare.
- BluePath Capital Management's largest Q3 2023 buy was Nicholas Fixed Income Alternative ETF: 1,285,161 shares worth $25.1M.
- BluePath Capital Management's ten largest holdings make up 49% of its $109M portfolio in Q3 2023.
- BluePath Capital Management disclosed 335 positions in Q3 2023, its first 13F filing on record.
Based on BluePath Capital Management's 13F filing for Q3 2023, filed 25 Oct 2023.